Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

940 publication(s) found matching the search criteria

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues


Author(s): Gallo M, Campione S, Di Vito V, Fortunati N, Lo Calzo F, Messina E, Ruggeri RM, Faggiano A, Colao AAL
Affiliated Institution / ERN: AO City of Health and Science - Turin ; AOU Federico II - Naples ; AOU polyclinic "G.Martino" of Messina ;
Condition / Disease: Neuroendocrine Neoplasm
Publication: Frontiers in Endocrinology v11 Year: 2021 ORPHAcode / other: ORPHA877
DOI: 10.3389/fendo.2020.610230 Keywords: breast cancer,breast carcinoma,breast neuroendocrine neoplasms,neuroendocrine,review

The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group


Author(s): van den Broek MFM, de Laat JM, van Leeuwaarde RS, van de Ven AC, de Herder WW, Dekkers OM, Drent ML, Kerstens MN, Bisschop PH, Havekes B, Hackeng WM, Brosens LAA, Vriens MR, Buikhuisen WA, Valk GD
Affiliated Institution / ERN: University Medical Center Utrecht ; Radboud University Medical Centre Nijmegen ; Leiden University Medical Center ; Amsterdam UMC ; Erasmus MC: University Medical Center Rotterdam ; Maastricht University Medical Center+ ;
Condition / Disease: Multiple endocrine neoplasia type 1
Publication: The Journal of Clinical Endocrinology & Metabolism v106.2 pe1014-e1027 Year: 2021 ORPHAcode / other: ORPHA652
DOI: 10.1210/clinem/dgaa800 Keywords: lung NET,multiple endocrine neoplasia type 1,surveillance,survival,tumor growth
MTG4

Serum insulin-like factor 3 quantification by LC–MS/MS in male patients with hypogonadotropic hypogonadism and Klinefelter syndrome


Author(s): Johannsen TH, Ljubicic ML, Young J, Trabado S, Petersen JH, Linneberg A, Albrethsen J, Juul A
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine 2021(2) Year: 2021 ORPHAcode / other:
DOI: 10.1007/s12020-021-02609-0 Keywords:
MTG7

Multidisciplinary Approach to the Child with Sex Chromosomal Mosaicism Including a Y-Containing Cell Line


Author(s): Debo B, Van Loocke M, De Groote K, De Leenheer E, Cools M
Affiliated Institution / ERN: Ghent University Hospital ;
Condition / Disease: Other
Publication: International Journal of Environmental Research and Public Health v18.3 p917 Year: 2021 ORPHAcode / other: ORPHA325546
DOI: 10.3390/ijerph18030917 Keywords: 45,X/46,XY mosaicism,Turner syndrome,germ cell cancer,growth hormone,sex chromosomal mosaicism
MTG7

Introduction to Endo-ERN–scope and mission


Author(s): Pereira AM, Hiort O
Affiliated Institution / ERN:
Condition / Disease: Endo-ERN
Publication: Endocrine 2021(2) Year: 2021 ORPHAcode / other: ORPHA97978
DOI: 10.1007/s12020-020-02602-z Keywords: Endo-ERN; scope; raising awareness; reference networks;
MTG1 MTG2 MTG3 MTG4 MTG5 MTG6 MTG7 MTG8

Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations


Author(s): Reincke M, Albani A, Assie G, Bancos I, Brue T, Buchfelder M, Chabre O, Ceccato F, Daniele A, Detomas M, Di Dalmazi G, Elenkova A, Findling J, Grossman AB, Gomez-Sanchez CE, Heaney AP, Honegger J, Karavitaki N, Lacroix A, Laws ER, Losa M, Murakami M, Newell-Price J, Pecori Giraldi F, Pérez‐Rivas LG, Pivonello R, Rainey WE, Sbiera S, Schopohl J, Stratakis CA, Theodoropoulou M, van Rossum EFC, Valassi E, Zacharieva S, Rubinstein G, Ritzel K
Affiliated Institution / ERN: Klinikum der Universität München ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; Assistance Publique-Hôpitaux de Marseille ; University Hospital of Padova ; University Hospital Würzburg ; AOU-Bologna ; San Raffaele hospital - Milan ; IRCCS Auxologico Italian Institute - Milan ; AOU Federico II - Naples ; Erasmus MC: University Medical Center Rotterdam ; Hospital de la Santa Creu i Sant Pau ;
Condition / Disease: Cushing disease
Publication: European Journal of Endocrinology v184.3 pP1-P16 Year: 2021 ORPHAcode / other: ORPHA96253
DOI: 10.1530/EJE-20-1088 Keywords:
MTG6

An Innovative Approach to Designing Digital Health Solutions Addressing the Unmet Needs of Obese Patients in Europe


Author(s): Patalano R, De Luca V, Vogt J, Birov S, Giovannelli L, Carruba G, Pivonello C, Stroetmann V, Triassi M, Colao A, Illario M
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: Obesity
Publication: International Journal of Environmental Research and Public Health v18.2 p579 Year: 2021 ORPHAcode / other: 5B81.00
DOI: 10.3390/ijerph18020579 Keywords: Europe,digital health,healthy food,healthy life,nutrition,obese patients,obesity
MTG5

Diazoxide-responsive hyperinsulinaemic hypoglycaemia in tyrosinaemia type 1


Author(s): Sotiridou E, Hoermann H, Aftab S, Dastamani A, Thimm E, Doodson L, Batzios S, Kummer S, Shah P
Affiliated Institution / ERN: Universitätsklinikum Düsseldorf ;
Condition / Disease: Diazoxide-sensitive diffuse hyperinsulinism
Publication: Endocrinology, Diabetes & Metabolism Case Reports v2021 Year: 2021 ORPHAcode / other: ORPHA165985
DOI: 10.1530/EDM-20-0174 Keywords:
MTG3

Molecular Differences Based on Erythrocyte Fatty Acid Profile to Personalize Dietary Strategies between Adults and Children with Obesity


Author(s): Jauregibeitia I, Portune K, Gaztambide S, Rica I, Tueros I, Velasco O, Grau G, Martín A, Castaño L, Larocca AV, Di Nolfo F, Ferreri C, Arranz S
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ; CHU de Toulouse ;
Condition / Disease: Obesity
Publication: Metabolites v11.1 p43 Year: 2021 ORPHAcode / other: 5B81.00
DOI: 10.3390/metabo11010043 Keywords: lipid metabolism,mature erythrocyte,obesity,precision nutrition
MTG5

The opera prevention project


Author(s): Muscogiuri G, Barrea L, Laudisio D, Pugliese G, Aprano S, Framondi L, Di Matteo R, Riccio PA, Savastano S, Colao A
Affiliated Institution / ERN:
Condition / Disease: Obesity
Publication: International Journal of Food Sciences and Nutrition v72.1 p1-3 Year: 2021 ORPHAcode / other: 5B81.00
DOI: 10.1080/09637486.2020.1765152 Keywords: Obesity,lifestyle,nutrition,physical activity,prevention
MTG5

GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice


Author(s): Biagetti B, Simó R
Affiliated Institution / ERN:
Condition / Disease: Acromegaly
Publication: International Journal of Molecular Sciences v22.1 p415 Year: 2021 ORPHAcode / other: ORPHA963
DOI: 10.3390/ijms22010415 Keywords: IGF-1,acromegaly,growth hormone,myopathy,review
MTG6

Nutritional status and follicular-derived thyroid cancer: An update


Author(s): Barrea L, Gallo M, Ruggeri RM, Giacinto PD, Sesti F, Prinzi N, Adinolfi V, Barucca V, Renzelli V, Muscogiuri G, Colao A, Baldelli R
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: Critical Reviews in Food Science and Nutrition v61.1 p25-59 Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.1080/10408398.2020.1714542 Keywords: Follicular thyroid cancer,dietary factors,dietary pattern,nutritional factors,nutritionist,obesity
MTG8

Papillary thyroid carcinoma arising in ectopic thyroid tissue within sternocleidomastoid muscle: a review of current literature


Author(s): BARREA L, FONDERICO F, DI SOMMA C, PUGLIESE G, DE ALTERIIS G, MASCOLO M, COLAO A, SAVASTANO S
Affiliated Institution / ERN:
Condition / Disease:
Publication: Minerva Endocrinologica v45.4 Year: 2021 ORPHAcode / other:
DOI: 10.23736/S0391-1977.20.03167-3 Keywords:

Somatostatin receptor ligands induce TSH deficiency in thyrotropin-secreting pituitary adenoma


Author(s): Illouz F, Chanson P, Sonnet E, Brue T, Ferriere A, Raffin Sanson M, Vantyghem M, Raverot G, Munier M, Rodien P, Briet C
Affiliated Institution / ERN: CHU d'Angers ; Assistance Publique-Hôpitaux de Marseille ; Hospices Civils de Lyon ;
Condition / Disease: TSH-secreting pituitary adenoma
Publication: European Journal of Endocrinology v184.1 p1-8 Year: 2021 ORPHAcode / other: ORPHA91347
DOI: 10.1530/EJE-20-0484 Keywords:
MTG6

Cardiovascular effects of overt and subclinical hyperthyroidism: focus on differentiated thyroid cancer


Author(s): Links TP, van der Boom T, Zandee WT, Lefrandt JD
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Follicular thyroid carcinoma
Publication: Endocrine Connections v10.1 pR43-R51 Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.1530/EC-20-0539 Keywords: cardiovascular risk,hyperthyroidism,thyroid carcinoma
MTG8

Diabetes y HOMA-IR en la acromegalia


Author(s): Biagetti B, Simó R
Affiliated Institution / ERN:
Condition / Disease: Acromegaly
Publication: Endocrinología, Diabetes y Nutrición v68.1 p1-2 Year: 2021 ORPHAcode / other: ORPHA963
DOI: 10.1016/j.endinu.2020.11.001 Keywords:
MTG6

Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature


Author(s): Bancos I, Atkinson E, Eng C, Young WF, Neumann HPH, Yukina M, Cohen DL, Waguespack SG, Pereira MAA, He X, Bandgar T, Donatini G, Qi X, Cohn A, Roslyakova A, Letizia C, Fishbein L, Kaur RJ, Iniguez-Ariza N, Murad MH, Gruber L, Wachtel H, Cherenko S, Jimenez C, Else T, Ramteke-Jadhav S, Fang X, Vaidya A, Petramala L, Beltsevich D, Walz MK, Corssmit EP, Wohllk N, Tufton N, Links TP, Ferrara AM, Tsoy U, Donegan D, Peczkowska M, Timmers HJ, Morelli V, Ebbehoj A, Kirschner LS, Kunavisarut T, Larsson C, Kudlai I, Hasse-Lazar K, Barczyński M, Deutschbein T, Langton K, Rasmussen ÃK, Dvorakova S, Miller JA, Liu L, Bennett B, Huang Y, Yu Z, Kumar Jaiswal S, Shah N, Diaz RE, Dullaart RP, Akker SA, Drake WM, Boaretto F, Zovato S, Barbon G, Taschin E, Schiavi F, Grineva E, Rappaport M, Skierczynski P, Fassnacht M, Calissendorff J, Juhlin CC, Vlĕek P, Li M, Jonasch E, Prokop L, Jovanovic M, Lechan RM, Erenler F, Garla V, Bobryk M, Kovalenko AY, Hodson E, Jenner B, Simpson HL, Casey RT, Gimm O, Ngeow Yuen Yie J, Shafigullina Z, Martins Bugalho MJ, Rizzati S, Fraenkel M, Sherlock M, Sarma D, Kaimal Saikia U, Riester A, Quinkler M, Zschiedrich S, Seufert J, Bausch B, Zavrashvili N, Søndergaard, E, Mathiesen JS, Robaczyk MG, Poulsen PL, Vasilkova V, Costa-Barbosa FA, Kater CE, Yildirim Simsir I, Ugurlu MU, Soyaltin UE, Makay Ã, Ivanov NV, Opocher G, Egorov VI, Petrov R, Khudiakova NV
Affiliated Institution / ERN:
Condition / Disease: Phaeochromocytoma and paraganglioma
Publication: The Lancet Diabetes & Endocrinology v9.1 p13-21 Year: 2021 ORPHAcode / other: ORPHA573163
DOI: 10.1016/S2213-8587(20)30363-6 Keywords:
MTG1 MTG4

Congenital isolated central hypothyroidism: Novel mutations and their functional implications


Author(s): Boelen A, van Trotsenburg AP, Fliers E
Affiliated Institution / ERN:
Condition / Disease: Congenital central hypothyroidism
Publication: Handbook of Clinical Neurology p161-169 Year: 2021 ORPHAcode / other: ORPHA226298
DOI: 10.1016/B978-0-12-820107-7.00010-0 Keywords: Coactivator,Corepressor,Hypothalamus,Hypothyroidism,Neonatal screening,Pituitary,TRH,TSH,Thyroid

Variants of SOS2 are a rare cause of Noonan syndrome with particular predisposition for lymphatic complications


Author(s): Lissewski C, Chune V, Pantaleoni F, De Luca A, Capri Y, Brinkmann J, Lepri F, Daniele P, Leenders E, Mazzanti L, Scarano E, Radio FC, Kutsche K, Kuechler A, Gérard M, Ranguin K, Legendre M, Vial Y, van der Burgt I, Rinne T, Andreucci E, Mastromoro G, Digilio MC, Cave H, Tartaglia M, Zenker M
Affiliated Institution / ERN: Universitätsklinikum Magdeburg ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; Radboud University Medical Centre Nijmegen ; AOU-Bologna ; University Hospital Essen ; Meyer Children’s Hospital Florence ; AOU Policlinico Umberto I - Rome ;
Condition / Disease: Noonan Syndrome
Publication: European Journal of Human Genetics v29.1 p51-60 Year: 2021 ORPHAcode / other: ORPHA648
DOI: 10.1038/s41431-020-00708-6 Keywords:
MTG5

European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis


Author(s): Muscogiuri G, El Ghoch M, Colao A, Hassapidou M, Yumuk V, Busetto L
Affiliated Institution / ERN: AOU Federico II - Naples ; University Hospital of Padova ;
Condition / Disease: Obesity
Publication: Obesity Facts v14.2 p222-245 Year: 2021 ORPHAcode / other: 5B81.00
DOI: 10.1159/000515381 Keywords: Body composition,Body mass index,Body weight,Clinical outcomes,Glycemic profile,Guidelines,Lipid profile,Obesity,Very low-calorie ketogenic diet,Weight loss

Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages


Author(s): Kliesch S, Schmidt S, Wilborn D, Aigner C, Albrecht W, Bedke J, Beintker M, Beyersdorff D, Bokemeyer C, Busch J, Classen J, de Wit M, Dieckmann K, Diemer T, Dieing A, Gockel M, Göckel-Beining B, Hakenberg OW, Heidenreich A, Heinzelbecker J, Herkommer K, Hermanns T, Kaufmann S, Kornmann M, Kotzerke J, Krege S, Kristiansen G, Lorch A, Müller A, Oechsle K, Ohloff T, Oing C, Otto U, Pfister D, Pichler R, Recken H, Rick O, Rudolph Y, Ruf C, Schirren J, Schmelz H, Schmidberger H, Schrader M, Schweyer S, Seeling S, Souchon R, Winter C, Wittekind C, Zengerling F, Zermann D, Zillmann R, Albers P
Affiliated Institution / ERN: ERN BOND ;
Condition / Disease: Germ Cell Tumours of the Testis
Publication: Urologia Internationalis v105.3-4 p169-180 Year: 2021 ORPHAcode / other:
DOI: 10.1159/000510407 Keywords: Clinical practice guideline,Diagnosis,Fertility preservation,Germ cell tumour of the testis,Prognosis,Staging

Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study


Author(s): Backeljauw P, Kanumakala S, Loche S, Schwab KO, Pfäffle RW, Höybye C, Lundberg E, Battelino T, Kriström B, Giemza T, Zouater H
Affiliated Institution / ERN: Karolinska University Hospital ; University Medical Centre Ljubljana ;
Condition / Disease: 45,X
Publication: Hormone Research in Paediatrics v94.3-4 p133-143 Year: 2021 ORPHAcode / other: ORPHA881
DOI: 10.1159/000515875 Keywords: Growth hormone replacement therapy,PATRO Children,Pediatric endocrinology,Turner syndrome
MTG7

A novel peptide antagonist of the human growth hormone receptor


Author(s): Basu R, Nahar K, Kulkarni P, Kerekes O, Sattler M, Hall Z, Neggers S, Holub JM, Kopchick JJ
Affiliated Institution / ERN: Erasmus MC: University Medical Center Rotterdam ;
Condition / Disease:
Publication: Journal of Biological Chemistry v296 p100588 Year: 2021 ORPHAcode / other:
DOI: 10.1016/j.jbc.2021.100588 Keywords: GH receptor,growth hormone,peptide antagonist,peptide mimetic,site 1-binding helix

Clinical Consequences of Variable Results in the Measurement of Free Thyroid Hormones: Unusual Presentation of a Family with a Novel Variant in the <b><i>THRB</i></b> Gene Causing Resistance to Thyroid Hormone Syndrome


Author(s): Campi I, Agostini M, Marelli F, de Filippis T, Romartinez-Alonso B, Rajanayagam O, Rurale G, Gentile I, Spagnolo F, Andreasi M, Ferraù F, Cannavò S, Fugazzola L, Chatterjee KV, Persani L
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; AOU polyclinic "G.Martino" of Messina ;
Condition / Disease: Resistance to thyroid hormone beta
Publication: European Thyroid Journal v10.6 p533-541 Year: 2021 ORPHAcode / other: ORPHA566243
DOI: 10.1159/000519748 Keywords: Anti-T4 antibodies,Central hyperthyroidism,Nodular goiter,RTHβ,THRB
MTG8

Surgical Practice in Girls with Congenital Adrenal Hyperplasia: An International Registry Study


Author(s): Hebenstreit D, Ahmed SF, Krone N, Krall C, Bryce J, Alvi S, Ortolano R, Lima M, Birkebaek N, Bonfig W, Claahsen van der Grinten H, Costa EC, Poyrazoglu S, de Vries L, Flück CE, Guran T, Bugrul F, Güven A, Iotova V, Koehler B, Schröder J, Konrad D, Gevers E, Krone R, Milenkovic T, Vieites A, Ross R, Tadokoro Cuccaro R, Hughes I, Acerini C, Springer A
Affiliated Institution / ERN: Copenhagen University Hospital, Rigshospitalet ; Sestre milosrdnice University Hospital Center ; AO City of Health and Science - Turin ; Assistance Publique-Hôpitaux de Marseille ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Sexual Development v15.4 p229-235 Year: 2021 ORPHAcode / other: ORPHA418
DOI: 10.1159/000517055 Keywords: Congenital adrenal hyperplasia,Disorders of sexual development,Intersex,Surgery
MTG7

Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience


Author(s): Scandurra C, Modica R, Maldonato NM, Dolce P, Dipietrangelo GG, Centello R, Di Vito V, Bottiglieri F, de Cicco F, Giannetta E, Isidori AM, Lenzi A, Muzii B, Faggiano A, Colao A
Affiliated Institution / ERN: AOU Federico II - Naples ; ERN BOND ;
Condition / Disease: Neuroendocrine Neoplasm
Publication: The Journal of Clinical Endocrinology & Metabolism v106.1 pe316-e327 Year: 2021 ORPHAcode / other: ORPHA877
DOI: 10.1210/clinem/dgaa760 Keywords: heterogeneity,metastases,neuroendocrine tumor,quality of life,resilience,severity

Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro‐osteogenic paracrine response: TERCELOI clinical trial


Author(s): Infante A, Gener B, Vázquez M, Olivares N, Arrieta A, Grau G, Llano I, Madero L, Bueno AM, Sagastizabal B, Gerovska D, Araúzo‐Bravo MJ, Astigarraga I, Rodríguez CI
Affiliated Institution / ERN: ERN BOND ;
Condition / Disease: Osteogenesis imperfecta
Publication: Clinical and Translational Medicine v11.1 Year: 2021 ORPHAcode / other: ORPHA666
DOI: 10.1002/ctm2.265 Keywords: cell therapy,mesenchymal stem cell,paracrine mechanism of action,regenerative medicine

The Efficacy and Short- and Long-Term Side Effects of Radioactive Iodine Treatment in Pediatric Graves’ Disease: A Systematic Review


Author(s): Lutterman SL, Zwaveling-Soonawala N, Verberne HJ, Verburg FA, van Trotsenburg AP, Mooij CF
Affiliated Institution / ERN: Amsterdam UMC ; Erasmus MC: University Medical Center Rotterdam ;
Condition / Disease: Paediatric-onset Graves disease
Publication: European Thyroid Journal v10.5 p353-363 Year: 2021 ORPHAcode / other: ORPHA525731
DOI: 10.1159/000517174 Keywords: Graves' disease,Pediatric Graves' disease,Radioactive iodine,Side effects
MTG8

Thyroid Dysfunction and Thyroid Cancer in Childhood Cancer Survivors: Prevalence, Surveillance and Management


Author(s): Lebbink C, Waguespack S, van Santen H
Affiliated Institution / ERN: University Medical Center Utrecht ;
Condition / Disease: Thyroid carcinoma
Publication: Frontiers of Hormone Research p140-153 Year: 2021 ORPHAcode / other: ORPHA100088
DOI: 10.1159/000513805 Keywords:
MTG8

Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain


Author(s): Iglesias P, Nocete I, Moure Rodríguez MD, Venegas-Moreno E, Ares J, Biagetti B, Rodríguez Berrocal V, Guerrero-Pérez F, Vicente A, Villar-Taibo R, Cordido F, Paja M, Glerean M, González Rivera N, Dios Fuentes E, Blanco C, Alvaréz-Escolá C, Martín T, Webb SM, Bernabéu I, Villabona C, Soto-Moreno A, Gaztambide S, Díez JJ
Affiliated Institution / ERN:
Condition / Disease: Craniopharyngioma
Publication: Neuroendocrinology v111.10 p925-936 Year: 2021 ORPHAcode / other: ORPHA54595
DOI: 10.1159/000512161 Keywords: Craniopharyngioma,Diabetes insipidus,Elderly,Hypopituitarism,Neurosurgery,Therapeutic outcome,Visual field defects
MTG6
Page 24 of 32« First«...10...2223242526...30...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2026. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance